Serina Therapeutics, Inc. Paid-in-Kind Interest
Serina Therapeutics, Inc. (SER) reported Paid-in-Kind Interest of $251.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2026-08-13
- Serina Therapeutics, Inc. paid-in-kind interest for the quarter ending 2026-06-30 was $126.00K.
- Serina Therapeutics, Inc. paid-in-kind interest for the quarter ending 2026-03-31 was $125.00K.
- Serina Therapeutics, Inc. paid-in-kind interest for the quarter ending 2025-12-31 was $138.00K, a 13700.00% increase year-over-year.
- Serina Therapeutics, Inc. paid-in-kind interest for the quarter ending 2025-09-30 was $0.00.
- Serina Therapeutics, Inc. paid-in-kind interest for fiscal 2025 was $138.00K, a 15.85% decline from fiscal 2024.
- Serina Therapeutics, Inc. paid-in-kind interest for fiscal 2024 was $164.00K, a 70.61% decline from fiscal 2023.
- Serina Therapeutics, Inc. paid-in-kind interest for fiscal 2023 was $558.00K.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $126.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $251.00K 10-Q · filed 2026-08-13 | $389.00K derived: sum of 3 quarters · filed 2026-08-13 | $389.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $125.00K 10-Q · filed 2026-05-14 | $263.00K derived: sum of 2 quarters · filed 2026-05-14 | $263.00K derived: sum of 3 quarters · filed 2026-05-14 | $263.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $138.00K derived: sum of 2 quarters · filed 2026-03-25 | $138.00K derived: sum of 3 quarters · filed 2026-08-13 | $138.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $0.00 10-Q · filed 2025-11-13 | $1.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $1.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | $1.00K derived: sum of 2 quarters · filed 2026-05-14 | $1.00K derived: sum of 3 quarters · filed 2026-05-14 | $1.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.00K derived: sum of 2 quarters · filed 2026-03-25 | $1.00K derived: sum of 3 quarters · filed 2026-03-25 | $164.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $163.00K 10-Q · filed 2025-11-13 | $339.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $163.00K 10-Q · filed 2025-08-11 | $339.00K derived: sum of 3 quarters · filed 2025-08-11 | |
| 2024-03-31 | $163.00K 10-Q · filed 2025-05-08 | $339.00K derived: sum of 2 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $176.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $558.00K 10-K · filed 2025-03-24 | ||
| 2023-09-30 | $382.00K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |